Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Atkins

Showing results (141-150 of 493) with videos related to

Pageof 50
Sort By:
Clinical Genitourinary Cancer|February 14, 2009
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinomaKathryn A Bylow, Michael B Atkins, Edwin M Posadas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684B E Hillner, J M Kirkwood, M B Atkins, et al.
Critical Care Medicine|November 1, 1995
Effects of malignancy and interleukin-2 infusion on gut macromolecular permeabilityC M Ryan, M B Atkins, J W Mier, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Possible myocardial toxicity associated with interleukin-4 therapyE G Trehu, J M Isner, J W Mier, et al.
The Journal of Biological Chemistry|March 28, 2018
Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosisLixia Zeng, Anna V Mathew, Jaeman Byun, et al.
Journal of Medical Economics|October 13, 2012
Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysisVictor Barzey, Michael B Atkins, Louis P Garrison, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2003
Acetylcholinesterase inhibitors activate septohippocampal GABAergic neurons via muscarinic but not nicotinic receptorsMin Wu, Samuel S Newton, Joshua B Atkins, et al.
Toxicology and Applied Pharmacology|April 2, 1999
Activation of poly [ADP-Ribose] polymerase in endothelial cells and keratinocytes: role in an in vitro model of sulfur mustard-mediated vesicationD B Hinshaw, I J Lodhi, L L Hurley, et al.
Diseases of the Colon and Rectum|April 1, 1994
Local excision of rectal carcinoma. Early results with combined chemoradiation therapy using 5-fluorouracil and leucovorinR A Graham, M B Atkins, D D Karp, et al.
Seminars in Oncology|December 8, 2009
Clinical trial experience with temsirolimus in patients with advanced renal cell carcinomaGary R Hudes, Anna Berkenblit, Jay Feingold, et al.
Pageof 50

Showing results (141-150 of 493) with videos related to

Sort By:
Pageof 50
Clinical Genitourinary Cancer|February 14, 2009
Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinomaKathryn A Bylow, Michael B Atkins, Edwin M Posadas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Economic analysis of adjuvant interferon alfa-2b in high-risk melanoma based on projections from Eastern Cooperative Oncology Group 1684B E Hillner, J M Kirkwood, M B Atkins, et al.
Critical Care Medicine|November 1, 1995
Effects of malignancy and interleukin-2 infusion on gut macromolecular permeabilityC M Ryan, M B Atkins, J W Mier, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1993
Possible myocardial toxicity associated with interleukin-4 therapyE G Trehu, J M Isner, J W Mier, et al.
The Journal of Biological Chemistry|March 28, 2018
Myeloperoxidase-derived oxidants damage artery wall proteins in an animal model of chronic kidney disease-accelerated atherosclerosisLixia Zeng, Anna V Mathew, Jaeman Byun, et al.
Journal of Medical Economics|October 13, 2012
Ipilimumab in 2nd line treatment of patients with advanced melanoma: a cost-effectiveness analysisVictor Barzey, Michael B Atkins, Louis P Garrison, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2003
Acetylcholinesterase inhibitors activate septohippocampal GABAergic neurons via muscarinic but not nicotinic receptorsMin Wu, Samuel S Newton, Joshua B Atkins, et al.
Toxicology and Applied Pharmacology|April 2, 1999
Activation of poly [ADP-Ribose] polymerase in endothelial cells and keratinocytes: role in an in vitro model of sulfur mustard-mediated vesicationD B Hinshaw, I J Lodhi, L L Hurley, et al.
Diseases of the Colon and Rectum|April 1, 1994
Local excision of rectal carcinoma. Early results with combined chemoradiation therapy using 5-fluorouracil and leucovorinR A Graham, M B Atkins, D D Karp, et al.
Seminars in Oncology|December 8, 2009
Clinical trial experience with temsirolimus in patients with advanced renal cell carcinomaGary R Hudes, Anna Berkenblit, Jay Feingold, et al.
Pageof 50